Central Nervous System Diseases: Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord.Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.Central Nervous System Viral Diseases: Viral infections of the brain, spinal cord, meninges, or perimeningeal spaces.Meningoencephalitis: An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions.Central Nervous System Infections: Pathogenic infections of the brain, spinal cord, and meninges. DNA VIRUS INFECTIONS; RNA VIRUS INFECTIONS; BACTERIAL INFECTIONS; MYCOPLASMA INFECTIONS; SPIROCHAETALES INFECTIONS; fungal infections; PROTOZOAN INFECTIONS; HELMINTHIASIS; and PRION DISEASES may involve the central nervous system as a primary or secondary process.Central Nervous System: The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.Brain: The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM.Subacute Sclerosing Panencephalitis: A rare, slowly progressive encephalitis caused by chronic infection with the MEASLES VIRUS. The condition occurs primarily in children and young adults, approximately 2-8 years after the initial infection. A gradual decline in intellectual abilities and behavioral alterations are followed by progressive MYOCLONUS; MUSCLE SPASTICITY; SEIZURES; DEMENTIA; autonomic dysfunction; and ATAXIA. DEATH usually occurs 1-3 years after disease onset. Pathologic features include perivascular cuffing, eosinophilic cytoplasmic inclusions, neurophagia, and fibrous gliosis. It is caused by the SSPE virus, which is a defective variant of MEASLES VIRUS. (From Adams et al., Principles of Neurology, 6th ed, pp767-8)AIDS Dementia Complex: A neurologic condition associated with the ACQUIRED IMMUNODEFICIENCY SYNDROME and characterized by impaired concentration and memory, slowness of hand movements, ATAXIA, incontinence, apathy, and gait difficulties associated with HIV-1 viral infection of the central nervous system. Pathologic examination of the brain reveals white matter rarefaction, perivascular infiltrates of lymphocytes, foamy macrophages, and multinucleated giant cells. (From Adams et al., Principles of Neurology, 6th ed, pp760-1; N Engl J Med, 1995 Apr 6;332(14):934-40)Brain Diseases: Pathologic conditions affecting the BRAIN, which is composed of the intracranial components of the CENTRAL NERVOUS SYSTEM. This includes (but is not limited to) the CEREBRAL CORTEX; intracranial white matter; BASAL GANGLIA; THALAMUS; HYPOTHALAMUS; BRAIN STEM; and CEREBELLUM.Maus Elberfeld virus: A strain of ENCEPHALOMYOCARDITIS VIRUS, a species of CARDIOVIRUS, usually causing an inapparent intestinal infection in mice. A small number of mice may show signs of flaccid paralysis.Cerebrospinal Fluid: A watery fluid that is continuously produced in the CHOROID PLEXUS and circulates around the surface of the BRAIN; SPINAL CORD; and in the CEREBRAL VENTRICLES.Meninges: The three membranes that cover the BRAIN and the SPINAL CORD. They are the dura mater, the arachnoid, and the pia mater.Demyelinating Diseases: Diseases characterized by loss or dysfunction of myelin in the central or peripheral nervous system.Enterovirus InfectionsAstrocytes: A class of large neuroglial (macroglial) cells in the central nervous system - the largest and most numerous neuroglial cells in the brain and spinal cord. Astrocytes (from "star" cells) are irregularly shaped with many long processes, including those with "end feet" which form the glial (limiting) membrane and directly and indirectly contribute to the BLOOD-BRAIN BARRIER. They regulate the extracellular ionic and chemical environment, and "reactive astrocytes" (along with MICROGLIA) respond to injury.Nervous System: The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed)Neurons: The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM.Magnetic Resonance Imaging: Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques.Disease Models, Animal: Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.Autonomic Nervous System Diseases: Diseases of the parasympathetic or sympathetic divisions of the AUTONOMIC NERVOUS SYSTEM; which has components located in the CENTRAL NERVOUS SYSTEM and PERIPHERAL NERVOUS SYSTEM. Autonomic dysfunction may be associated with HYPOTHALAMIC DISEASES; BRAIN STEM disorders; SPINAL CORD DISEASES; and PERIPHERAL NERVOUS SYSTEM DISEASES. Manifestations include impairments of vegetative functions including the maintenance of BLOOD PRESSURE; HEART RATE; pupil function; SWEATING; REPRODUCTIVE AND URINARY PHYSIOLOGY; and DIGESTION.Lamin Type A: A subclass of developmentally regulated lamins having a neutral isoelectric point. They are found to disassociate from nuclear membranes during mitosis.Cells, Cultured: Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others.Digestive System Diseases: Diseases in any part of the GASTROINTESTINAL TRACT or the accessory organs (LIVER; BILIARY TRACT; PANCREAS).Peripheral Nervous System: The nervous system outside of the brain and spinal cord. The peripheral nervous system has autonomic and somatic divisions. The autonomic nervous system includes the enteric, parasympathetic, and sympathetic subdivisions. The somatic nervous system includes the cranial and spinal nerves and their ganglia and the peripheral sensory receptors.Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.Cause of Death: Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.Enteric Nervous System: Two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gallbladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation. (From Kandel, Schwartz, and Jessel, Principles of Neural Science, 3d ed, p766)Autopsy: Postmortem examination of the body.Central Nervous System Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.Heart Conduction System: An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart.Autonomic Nervous System: The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.Immune System Diseases: Disorders caused by abnormal or absent immunologic mechanisms, whether humoral, cell-mediated, or both.Endocrine System Diseases: Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES.Sympathetic Nervous System: The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.Nervous System Physiological Phenomena: Characteristic properties and processes of the NERVOUS SYSTEM as a whole or with reference to the peripheral or the CENTRAL NERVOUS SYSTEM.Mutation: Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.Immunohistochemistry: Histochemical localization of immunoreactive substances using labeled antibodies as reagents.Time Factors: Elements of limited time intervals, contributing to particular results or situations.Nervous System Neoplasms: Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms.Infant, Newborn: An infant during the first month after birth.Risk Factors: An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.Cohort Studies: Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.

*  Research Type by WU name - please update

This receptor is involved in many complex pathways in the central nervous system and its dysfunction affects in a variety of ... This protein appears to be altered in cancer and other inflammatory diseases. ...

*  A Study of Dementia and Neurological Problems in HIV Infected Patients Who Are Participating in ACTG A5175 - Full Text View -...

Sexually Transmitted Diseases, Viral. Sexually Transmitted Diseases. Immunologic Deficiency Syndromes. Immune System Diseases. ... Both the central and peripheral nervous systems (CNS and PNS) are affected by HIV; however, the causes of neurotoxicity in HIV ... Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active ... Albright AV, Soldan SS, González-Scarano F. Pathogenesis of human immunodeficiency virus-induced neurological disease. J ...

*  Neurological Complications of Infective EndocarditisClinical Perspective | Circulation

nervous system. *complications. Introduction. Infective endocarditis (IE) remains a major clinical problem, with mortality ... Infectious Diseases Unit Hospital Juan Ramón Jiménez, Huelva, Spain (J.M.L., F.J.M.-M.); Clinical Service of Infectious Disease ... Infectious Diseases Unit Hospital Juan Ramón Jiménez, Huelva, Spain (J.M.L., F.J.M.-M.); Clinical Service of Infectious Disease ... Infectious Diseases Unit Hospital Juan Ramón Jiménez, Huelva, Spain (J.M.L., F.J.M.-M.); Clinical Service of Infectious Disease ...

*  Neurological Problems and Management | Stroke | Meningitis

Central nervous system (CNS) - coordinates and controls body functions 1. Brain a. cerebrum i. hemispheres right and left ii. ... Syphilitic meningitis is usually diagnosed with serological tests for the disease, such as the venereal disease research ... respond to sympathetic nervous system with dilation e. ciliary body (smooth muscle) contracts to reduce tension of suspensory ... E. Physiology - nervous system coordinates and controls all activities of the body 1. Receives internal and external stimuli 2 ...

*  Ocular Emergencies - Alpenglow Veterinary Specialty + Emergency Center

Central nervous system disease-an animal that is blind due to central nervous system disease commonly has other clinical signs ... Some of these diseases involve only the eye and others involve other neurologic (i.e., central nervous system) problems. It's ... It can occur from trauma, from hypertension, or from other systemic diseases such as ehrlichiosis. Retinal detachments can be ...

*  A growing segment of neurologically impaired children is increasingly dependent on children's hospitals - Healthcanal.com :...

Heart disease. 09/19/2017 Heart disease Metabolism switch signals end for healing hearts ... Kidneys and Urinary System*Male Reproductive*Low Testosterone. *Oral and Dental Health*Palliative Care*Pregnancy and Childbirth ... "We're nervous that many children with neurologic impairment are without a healthcare provider who is taking charge of their ... 09/19/2017 Heart disease Metabolism switch signals end for healing hearts ...

*  Modeling human neurological disorders with induced pluripotent stem cells - Imaizumi - 2013 - Journal of Neurochemistry - Wiley...

... including nervous system, hematopoietic system, and metabolic system diseases, and investigations of their pathology are ... Modeling neurological diseases in vitro with disease-specific iPS cells * Modeling Familial PDs with disease-specific iPS cells ... The pathological investigation of disease progression, including disease onset and the time course of disease advance, requires ... it is not easy to construct human disease models for sporadic diseases in a test tube, even by using disease-specific iPS cells ...
onlinelibrary.wiley.com/doi/10.1111/jnc.12625/full?globalMessage=0&systemMessage=Wiley Online Library will be unavailable on Saturday 7th Oct from 03.00 EDT / 08:00 BST / 12:30 IST / 15.00 SGT to 08.00 EDT / 13.00 BST / 17:30 IST / 20.00 SGT and Sunday 8th Oct from 03.00 EDT / 08:00 BST / 12:30 IST / 15.00 SGT to 06.00 EDT / 11.00 BST / 15:30 IST / 18.00 SGT for essential maintenance. Apologies for the inconvenience caused

*  DMOZ - Health: Conditions and Diseases: Neurological Disorders

Sites dealing with strictly medical aspects of neurological diseases (e.g. sites intended for healthcare providers) should be ... Health/Conditions and Diseases/Neurological Diseases deals with the health aspects of neurological problems. ... Health/Conditions and Diseases/Neurological Diseases deals with the health aspects of neurological problems. Sites dealing with ... Parkinson'-s Disease 52 Peripheral Nervous System 98 Pituitary Disorders 27 Porencepha-ly 2 ...

*  Nervous System Diseases/Disorders by Celia Jackson on Prezi

Nervous System Diseases/Disorders. By: Celia Jackson, Benjamin Tang, John Vollmer, and Edie Royal ... Transcript of Nervous System Diseases/Disorders. Concussions A concussion is a minor traumatic brain injury, most commonly ... Tourettes Symptoms of a concussion Tourettes is a disease of the nervous system that is characterized by involuntary, ... Nervous System Diseases/Disorders By: John, Edie, Celia, and Ben Spastic Cerebral Palsy. Athetoid Cerebral Palsy. Ataxic ...

*  Central Nervous System Diseases by Dr.Michael Booth Scofield on Prezi

Transcript of Central Nervous System Diseases. CENTRAL NERVOUS SYSTEM DISEASES CENTRAL NERVOUS SYSTEM DISEASES By : Mufaidha ... BCAS Parkinson's Disease. Depression. Epilepsy PARKINSON'S DISEASE a chronic, progressive disorder that affects nerve cells ... Parkinson's disease Drugs Sometimes a dopamine agonist is used in combination with levodopa in the later stages of PD. ... Parkinson's disease may also result if the receptors to which dopamine must bind to exert its effects become blocked. • ...

*  Nervous System Diseases - Neurological Disorders Summary Report | CureHunter

Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, ... peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle. ... Nervous System Disease; Nervous System Disorders; Neurologic Disorder; Neurologic Disorders; Disease, Nervous System; Diseases ... Disease Context: Research Results. *Nervous System Diseases: 6158*Neurodegenerative Diseases: 16953. *Demyelinating Diseases: ...

*  Search of: Recruiting, Not yet recruiting, Available Studies | 'Nervous System Diseases' - List Results - ClinicalTrials.gov

IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... ...
https://clinicaltrials.gov/ct2/results?recr=Open&cond="Nervous System Diseases"&pg=2

*  Central Nervous System Disease Treatments, CNS Drugs |Teva Pharmaceutical Industries

Teva Pharmaceuticals provides specialty pharmaceutical products for central nervous system (CNS) disorders including Multiple ... Central Nervous System (CNS). Teva is committed to delivering medicines to meet the needs of patients and families affected by ... A global leader in treatments for disorders of the central nervous system (CNS), Teva provides products to treat patients with ... disorders of the Central Nervous System (CNS). Share on Facebook. Share on LinkedIn. ...

*  Flashcards - Nervous System Disease

What causes peripheral nervous system diseases? *idiopathic vestibular disease*neuropathies - metabolic - hypothyroid, diabetes ... disease of the nervous system due to a metabolic disease - hypothyroidism, diabetes mellitus ... Nervous System Disease. Home , Preview The flashcards below were created by user kris10leejmu on FreezingBlue Flashcards. * Get ... How do we diagnose idiopathic vestibular disease? *clinical signs*blood work to rule out underlying disease*otic exam to rule ...

*  Nervous system Lyme disease

... burgdorferi is the principal cause of the disease in the United States. All three pathogenic ... Lyme disease is a tick-borne illness caused primarily by three pathogenic species of the spirochete Borrelia (B. burgdorferi, B ... Nervous system Lyme disease. Author. John J Halperin, MD, FAAN, FACP. John J Halperin, MD, FAAN, FACP ... Nervous system abnormalities in Lyme disease. Ann N Y Acad Sci 1988; 539:24. ...

*  Nervous system diseases and disorders

... Ablative Fowler finagle that mutches cryptogamist exhilaratingly. nervous system ... Dreamy Rice reluctantly, nervous system diseases and disorders his etymologising well to the west. Walter yellowish betokens, ... Sinódico presumption that entomologically reactivated? Saw pear shaped and nervous system diseases and disorders their showers ... Federated and paying Lucius paiks nervous system diseases and disorders seddon nerve injury classification tiles and metred ...

*  Free the nervous system diseases downloads

Nervous System 3D: In this study: Anatomy of Nervous System, are being shown, each and every one of its parts, functions, ... Nervous System: In this study: Anatomy of Nervous System, are being shown, each and every one of its parts, functions, ... 3D Brain & Nervous System Anatomy contains the entire human nervous system, including all cranial and spinal nerves, a ... Test and improve your knowledge answering the questions and learn new facts about Human Nervous System with Nervous System Quiz ...

*  The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the...

Title: The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the ... The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the ... The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the ... Keywords: Sigma receptor, central nervous system, schizophrenia, anxiety, depression, Alzheimer's disease, addiction, pain, ...

*  Smashwords - Diseases / nervous system (incl. brain)

Nonfiction » Health, wellbeing, & medicine » Diseases / nervous system (incl. brain). Morton Neuroma, A Simple Guide To The ... Categories: Nonfiction » Health, wellbeing, & medicine » Diseases / nervous system (incl. brain) Terrified children in our ... Categories: Nonfiction » Health, wellbeing, & medicine » Diseases / nervous system (incl. brain), Nonfiction » Inspiration » ... Categories: Nonfiction » Psychology » Mental health, Nonfiction » Health, wellbeing, & medicine » Diseases / nervous system ( ...

*  Nervous System Diseases Tier 2 M96 - Pathway Predesigned Plate | Life Science Research | Bio-Rad

Nervous System Diseases Tier 2 M96. Predesigned 96-well panel for use with SYBR® Green ...

*  Profile of central nervous system disease in HIV/AIDS patients...

Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.: The study ... Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.. Authors * ...

*  The Translocator Protein (18 kDa): Central Nervous System Disease and Drug Design

... ... SP/I/1/77065/10 by the strategic scientific research and experimental development program: SYNAT - "Interdisciplinary System ...

*  Central nervous system--Diseases

... Information about the Resource. Schema.org Name(s): Controlled Heading Identifier: * http:// ...

*  Lectures on the Nervous System and Its Diseases - Marshall Hall; | Foyles Bookstore

You are browsing: All Lectures on the Nervous System and Its Diseases ...

*  Conditions and Diseases -- Nervous System and Sense Organs | TriStar Health

Nervous System and Sense Organs at TriStar Health ABCDEFGHIJKLMNOPRSTUVWXZ ... ...

Central nervous system disease: A central nervous system disease can affect either the spinal cord (myelopathy) or brain (encephalopathy), both of which are part of the central nervous system.Central nervous system viral disease: A central nervous system viral disease is a viral infection that affects the central nervous system.Pug: The Pug is a breed of dog with a wrinkly, short-muzzled face and curled tail. The breed has a fine, glossy coat that comes in a variety of colours, most often fawn or black, and a compact square body with well-developed muscles.Progressive rubella panencephalitis: Progressive rubella panencephalitis (PRP) is a neurological disorder which may occur in a child with congenital rubella. It is a slow viral infection of the brain characterized by chronic encephalitis, usually manifesting between 8–19 years of age.Cognitive effects of HIVDemyelinating disease: -, |Keshan diseaseAstrocyte: Astrocytes (Astro from Greek astron = star and cyte from Greek "kyttaron" = cell), also known collectively as astroglia, are characteristic star-shaped glial cells in the brain and spinal cord. The proportion of astrocytes in the brain is not well defined.HSD2 neurons: HSD2 neurons are a small group of neurons in the brainstem which are uniquely sensitive to the mineralocorticosteroid hormone aldosterone, through expression of HSD11B2. They are located within the caudal medulla oblongata, in the nucleus of the solitary tract (NTS).HyperintensityGross pathology: Gross pathology refers to macroscopic manifestations of disease in organs, tissues, and body cavities. The term is commonly used by anatomical pathologists to refer to diagnostically useful findings made during the gross examination portion of surgical specimen processing or an autopsy.Methylsterol monooxygenase: Methylsterol monooxygenase (, methylsterol hydroxylase, 4-methylsterol oxidase, 4,4-dimethyl-5alpha-cholest-7-en-3beta-ol,hydrogen-donor:oxygen oxidoreductase (hydroxylating)) is an enzyme with system name 4,4-dimethyl-5alpha-cholest-7-en-3beta-ol,NAD(P)H:oxygen oxidoreductase (hydroxylating). This enzyme catalyses the following chemical reactionPrifinium bromideVincristineNeurogastroenterology: Neurogastroenterology encompasses the study of the brain, the gut, and their interactions with relevance to the understanding and management of gastrointestinal motility and functional gastrointestinal disorders. Specifically, neurogastroenterology focuses on the functions, malfunctions, and the malformations of the sympathetic, parasympathetic, and enteric divisions of the digestive tract.Death of Ludwig van Beethoven: The death of Ludwig van Beethoven on 26 March 1827 followed a prolonged illness. It was witnessed by his sister-in-law and by his close friend Anselm Hüttenbrenner, who provided a vivid description of the event.OdulimomabBMC Endocrine Disorders: BMC Endocrine Disorders is an open access peer-reviewed scientific journal publishing original research articles in all aspects of the prevention, diagnosis and management of endocrine disorders, as well as related molecular genetics, pathophysiology, and epidemiology.References ==Silent mutation: Silent mutations are mutations in DNA that do not significantly alter the phenotype of the organism in which they occur. Silent mutations can occur in non-coding regions (outside of genes or within introns), or they may occur within exons.Temporal analysis of products: Temporal Analysis of Products (TAP), (TAP-2), (TAP-3) is an experimental technique for studyingEpidemiology of cancer: The epidemiology of cancer is the study of the factors affecting cancer, as a way to infer possible trends and causes. The study of cancer epidemiology uses epidemiological methods to find the cause of cancer and to identify and develop improved treatments.QRISK: QRISK2 (the most recent version of QRISK) is a prediction algorithm for cardiovascular disease (CVD) that uses traditional risk factors (age, systolic blood pressure, smoking status and ratio of total serum cholesterol to high-density lipoprotein cholesterol) together with body mass index, ethnicity, measures of deprivation, family history, chronic kidney disease, rheumatoid arthritis, atrial fibrillation, diabetes mellitus, and antihypertensive treatment.

(1/3079) Retarded growth and deficits in the enteric and parasympathetic nervous system in mice lacking GFR alpha2, a functional neurturin receptor.

Glial cell line-derived neurotrophic factor (GDNF) and a related protein, neurturin (NTN), require a GPI-linked coreceptor, either GFR alpha1 or GFR alpha2, for signaling via the transmembrane Ret tyrosine kinase. We show that mice lacking functional GFR alpha2 coreceptor (Gfra2-/-) are viable and fertile but have dry eyes and grow poorly after weaning, presumably due to malnutrition. While the sympathetic innervation appeared normal, the parasympathetic cholinergic innervation was almost absent in the lacrimal and salivary glands and severely reduced in the small bowel. Neurite outgrowth and trophic effects of NTN at low concentrations were lacking in Gfra2-/- trigeminal neurons in vitro, whereas responses to GDNF were similar between the genotypes. Thus, GFR alpha2 is a physiological NTN receptor, essential for the development of specific postganglionic parasympathetic neurons.  (+info)

(2/3079) Anti-amphiphysin I antibodies in patients with paraneoplastic neurological disorders associated with small cell lung carcinoma.

Patients with stiff man syndrome and breast cancer develop anti-amphiphysin I antibodies that primarily recognise the C terminus of the protein. Anti-amphiphysin I antibodies have also been identified in a few patients with paraneoplastic neurological disorders (PND) and small cell lung cancer (SCLC). The frequency of anti-amphiphysin I antibodies in patients with SCLC and PND was analysed and the epitope specificity of these antibodies was characterised. Anti-amphiphysin I antibodies were evaluated by immunohistochemistry on human and rat cerebellum and immunoblots of rat brain homogenates. Serum samples included 134 patients with PND and anti-Hu antibodies (83% had SCLC), 44 with SCLC and PND without anti-Hu-antibodies, 63 with PND and either Yo, Ri, or Tr antibodies, 146 with SCLC without PND, and 104 with non-PND. Positive serum samples were confirmed with immunoblots of recombinant human amphiphysin I and immunoreacted with five overlapping peptide fragments covering the full length of the molecule. Serum samples positive for anti-amphiphysin I antibodies included those from seven (2.9%) patients with PND and two (1.4%) with SCLC without PND. Six of the seven anti-amphiphysin I antibody positive patients with PND had SCLC (three with Hu-antibodies), and one had anti-Hu-antibodies but no detectable tumour. The PND included encephalomyelitis/sensory neuropathy (five patients), cerebellar degeneration (one), and opsoclonus (one). All anti-amphiphysin I antibodies reacted with the C terminus of amphiphysin I, but seven also recognised other fragments of the molecule. In conclusion, anti-amphiphysin I antibodies are present at low frequency in patients with SCLC irrespective of the presence of an associated PND. All anti-amphiphysin I antibody positive serum samples have in common reactivity with the C terminus of the protein.  (+info)

(3/3079) Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix.

PURPOSE: Both paclitaxel and cisplatin have moderate activity in patients with metastatic or recurrent cancer of the cervix, and the combination of these two agents has shown activity and possible synergism in a variety of solid tumors. We administered this combination to patients with metastatic or recurrent cervical cancer to evaluate its activity. PATIENTS AND METHODS: Thirty-four consecutive patients were treated on an outpatient basis with paclitaxel 175 mg/m2 administered intravenously over a 3-hour period followed by cisplatin 75 mg/m2 administered intravenously with granulocyte colony-stimulating factor support. The chemotherapy was administered every 3 weeks for a maximum of six courses. RESULTS: Sixteen patients (47%; 95% confidence interval, 30% to 65%) achieved an objective response, including five complete responses and 11 partial responses. Responses occurred in 28% of patients with disease within the radiation field only and in 57% of patients with disease involving other sites. The median duration of response was 5.5 months, and the median times to progression and survival for all patients were 5 and 9 months, respectively. Grade 3 or 4 toxicities included anemia in 18% of patients and granulocytopenia in 15% of patients. Fifty-three percent of patients developed some degree of neurotoxicity; 21% of cases were grade 2 or worse. CONCLUSION: The combination of paclitaxel with cisplatin seems relatively well tolerated and moderately active in patients with metastatic or recurrent cervical cancer. The significant incidence of neurotoxicity is of concern, and alternative methods of administration of the two agents could be evaluated. Then, further study of this combination, alone or with the addition of other active agents, is warranted.  (+info)

(4/3079) Nitric oxide, mitochondria and neurological disease.

Damage to the mitochondrial electron transport chain has been suggested to be an important factor in the pathogenesis of a range of neurological disorders, such as Parkinson's disease, Alzheimer's disease, multiple sclerosis, stroke and amyotrophic lateral sclerosis. There is also a growing body of evidence to implicate excessive or inappropriate generation of nitric oxide (NO) in these disorders. It is now well documented that NO and its toxic metabolite, peroxynitrite (ONOO-), can inhibit components of the mitochondrial respiratory chain leading, if damage is severe enough, to a cellular energy deficiency state. Within the brain, the susceptibility of different brain cell types to NO and ONOO- exposure may be dependent on factors such as the intracellular reduced glutathione (GSH) concentration and an ability to increase glycolytic flux in the face of mitochondrial damage. Thus neurones, in contrast to astrocytes, appear particularly vulnerable to the action of these molecules. Following cytokine exposure, astrocytes can increase NO generation, due to de novo synthesis of the inducible form of nitric oxide synthase (NOS). Whilst the NO/ONOO- so formed may not affect astrocyte survival, these molecules may diffuse out to cause mitochondrial damage, and possibly cell death, to other cells, such as neurones, in close proximity. Evidence is now available to support this scenario for neurological disorders, such as multiple sclerosis. In other conditions, such as ischaemia, increased availability of glutamate may lead to an activation of a calcium-dependent nitric oxide synthase associated with neurones. Such increased/inappropriate NO formation may contribute to energy depletion and neuronal cell death. The evidence available for NO/ONOO--mediated mitochondrial damage in various neurological disorders is considered and potential therapeutic strategies are proposed.  (+info)

(5/3079) The effects of specific antibody fragments on the 'irreversible' neurotoxicity induced by Brown snake (Pseudonaja) venom.

Brown snake (Pseudonaja) venom has been reported to produce 'irreversible' post synaptic neurotoxicity (Harris & Maltin, 1981; Barnett et al., 1980). A murine phrenic nerve/diaphragm preparation was used to study the neurotoxic effects of this venom and pre- and post-synaptic components were distinguished by varying the temperature and frequency of nerve stimulation. There were no myotoxic effects and the neurotoxicity proved irreversible by washing alone. The effects of a new Fab based ovine antivenom have been investigated and proved able to produce a complete, rapid (< 1 h) reversal of the neurotoxicity induced by Brown snake venom. A reversal was also possible when the antivenom addition was delayed for a further 60 min. We believe that this is the first time such a reversal has been shown.  (+info)

(6/3079) Incidence of cranial ultrasound abnormalities in apparently well neonates on a postnatal ward: correlation with antenatal and perinatal factors and neurological status.

AIM: To evaluate cranial ultrasonography and neurological examination in a cohort of infants regarded as normal; and to determine the prevalence of ultrasound abnormalities and any potential association with antenatal or perinatal factors or deviant neurological signs. METHODS: Cranial ultrasound findings and neurological status were evaluated in 177 newborns (gestational age 36.3 to 42 weeks), admitted to a postnatal ward directly after birth and regarded as normal by obstetric and paediatric staff. The age of the infants at the time of examination ranged between 6 and 48 hours. Ultrasound abnormalities were present in 35 of the 177 infants studied (20%). Ischaemic lesions, such as periventricular and thalamic densities were the most common finding (8%), followed by haemorrhagic lesions (6%). The possible sequelae of antenatal haemorrhages, such as focal ventricular dilatation or choroid cysts, were present in 6%. Abnormal ultrasound findings were not significantly associated with signs of perinatal distress, such as cardiotocographic abnormalities or passage of meconium. Abnormal ultrasound findings tended to be associated with antenatal problems, although this did not reach significance. Ultrasound abnormalities were strongly associated with deviant patterns on the neurological examination. CONCLUSIONS: These results suggest that ultrasound abnormalities are more common than has been reported up to now. Lesions that could be ischaemic, such as flare densities, are seen even in the absence of any antenatal or perinatal risk factor.  (+info)

(7/3079) Neurology and the skin.

As knowledge of pathophysiology grows, so does the refinement of diagnoses. Sometimes increased knowledge permits consolidation and unification. Unfortunately, at our present level of understanding, it usually demands proliferation of diagnostic categories. As tedious as this diagnostic splintering may seem, such is the price currently exacted of both the investigator and the clinician who seek to optimise management. Increased diagnostic refinement often requires inquiry into matters outside the bounds of one's specialty. Most often we turn to the radiologist or to the laboratory to narrow the differential diagnosis generated from the history and neurological examination. As we have shown, a useful intermediate step is extension of the physical examination to organs such as the skin, which are not the traditional preserve of the neurologist. That any text could confer the sophistication required for expert dermatological diagnosis is an unrealistic expectation. However, we hope that this review will encourage careful examination of the skin, hair, and nails by the neurological practitioner, with consideration of referral to a dermatologist when greater expertise is required.  (+info)

(8/3079) Assessing the machinery of mind: synapses in neuropsychiatric disorders.

Neural connectivity in postmortem human brain can now be studied with the use of antibodies that react with synapse-enriched proteins. Using a range of antibody-based techniques, the authors observed abnormalities in connectivity in Alzheimer's disease, temporal lobe epilepsy, and schizophrenia. They also found disease-related differences in the individual protein markers affected and in the anatomical distribution of differences from controls. Molecular and cellular abnormalities in neural connectivity may underlie functional abnormalities observed in vivo using positron emission tomography or functional magnetic resonance imaging.  (+info)

Infectious Diseases

  • Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. (uptodate.com)


  • Central nervous system complications after liver transplantation: common but mostly transient phenomena. (sigmaaldrich.com)
  • Although central nervous system complications (CNSCs) are common after orthotopic liver transplantation (OLT), standardized prospective studies are still lacking. (sigmaaldrich.com)
  • With advances in brain imaging and completion of randomized clinical trials (RCTs) for primary and secondary stroke prevention, the natural history of central nervous system (CNS) complications in sickle cell disease (SCD) is evolving. (bloodjournal.org)


  • Patients with central nervous system (CNS) symptoms but negative imaging and cerebrospinal fluid results and patients with pontine myelinolysis or posterior reversible encephalopathy syndrome were placed in a metabolic-toxic CNSC group, and patients with strokes, intracranial hemorrhaging, or CNS infections were placed in a nonmetabolic CNSC group. (sigmaaldrich.com)
  • Individuals with AIDS frequently suffer central nervous system (CNS) problems that are characterized by cognitive, motor, and behavioral deficits, in a disorder known as AIDS dementia complex. (clinicaltrials.gov)
  • In the last 40 years, significant clinical research efforts have been focused on preventing initial and subsequent central nervous system (CNS) injuries. (bloodjournal.org)
  • Have a history of central nervous system infections. (clinicaltrials.gov)


  • There is no cure for SSPE, but certain antiviral drugs can slow the progression of the disease. (callfred.com)